Aeglea BioTherapeutics
is building a potentially best in class pipeline with next generation and rational combinations strategy target program discovery clinical | Aeglea BioTherapeutics
Deck date
September 2023
Slide
38 of 56
Similar slides by Aeglea BioTherapeutics
Investor Presentation
September 2023
Investor Presentation
September 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Related slides by other companies
Investor Presentation
August 2023
Investor Presentation
November 2023
Investor Presentation
July 2023
Investor Presentation
August 2023
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io